B type natriuretic peptide testing: where are we now?

被引：9

作者：

Cowie, MR ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci & Technol, Natl Heart & Lung Inst, London SW3 6LY, England

来源：

HEART | 2004年 / 90卷 / 07期

关键词：

D O I：

10.1136/hrt.2003.014787

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is possible that plasma BNP measurement might be to heart failure what glycated haemoglobin measurement is to diabetes mellitus. Indeed, within 12 - 24 months, BNP testing might become a routine addition to the monitoring of patients with heart failure. In the meantime its main role is in helping to rule out heart failure in patients with new symptoms.

引用

页码：725 / 726

页数：2

共 18 条

[1] A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study [J].

Cheng, V ;

Kazanagra, R ;

Garcia, A ;

Lenert, L ;

Krishnaswamy, P ;

Gardetto, N ;

Clopton, P ;

Maisel, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :386-391

[2] BNP and congestive heart failure [J].

Cowie, MR ;

Mendez, GF .

PROGRESS IN CARDIOVASCULAR DISEASES, 2002, 44 (04) :293-321

[3] Clinical applications of B-type natriuretic peptide (BNP) testing [J].

Cowie, MR ;

Jourdain, P ;

Maisel, A ;

Dahlstrom, U ;

Follath, F ;

Isnard, R ;

Luchner, A ;

McDonagh, T ;

Mair, J ;

Nieminen, M ;

Francis, G .

EUROPEAN HEART JOURNAL, 2003, 24 (19) :1710-1718

[4] Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].

Cowie, MR ;

Struthers, AD ;

Wood, DA ;

Coats, AJS ;

Thompson, SG ;

PooleWilson, PA ;

Sutton, GC .

LANCET, 1997, 350 (9088) :1349-1353

[5] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting [J].

Dao, Q ;

Krishnaswamy, P ;

Kazanegra, R ;

Harrison, A ;

Amirnovin, R ;

Lenert, L ;

Clopton, P ;

Alberto, J ;

Hlavin, P ;

Maisel, AS .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) :379-385

[6] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].

de Lemos, JA ;

Morrow, DA ;

Bentley, JH ;

Omland, T ;

Sabatine, MS ;

McCabe, CH ;

Hall, C ;

Cannon, CP ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021

[7] N-terminal pro-brain natriuretic peptide -: A new gold standard in predicting mortality in patients with advanced heart failure [J].

Gardner, RS ;

Özalp, F ;

Murday, AJ ;

Robb, SD ;

McDonagh, TA .

EUROPEAN HEART JOURNAL, 2003, 24 (19) :1735-1743

[8] Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations [J].

Hobbs, FDR ;

Davis, RC ;

Roalfe, AK ;

Hare, R ;

Davies, MK ;

Kenkre, JE .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7352) :1498-1500A

[9] Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction - Results from the breathing not properly multinational study [J].

Maisel, AS ;

McCord, J ;

Nowak, RM ;

Hollander, JE ;

Wu, AHB ;

Duc, P ;

Omland, T ;

Storrow, AB ;

Krishnaswamy, P ;

Abraham, WT ;

Clopton, P ;

Steg, G ;

Aumont, MC ;

Westheim, A ;

Knudsen, CW ;

Perez, A ;

Kamin, R ;

Kazanegra, R ;

Herrmann, HC ;

McCullough, PA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2010-2017

[10] Biochemical detection of left-ventricular systolic dysfunction [J].

McDonagh, TA ;

Robb, SD ;

Murdoch, DR ;

Morton, JJ ;

Ford, I ;

Morrison, CE ;

Tunstall-Pedoe, H ;

McMurray, JJV ;

Dargie, HJ .

LANCET, 1998, 351 (9095) :9-13

← 1 2 →